A sense of de ja vu descends as news reports and WHO bulletins produce a mixture of fear and calm mongering. Hantavirus is nothing to worry about; evidence of human-to-human transmission is rare/understudied; it doesn’t meet epidemic proportions. A repeat of January 2020’s farce all while globalised transport infrastructure spread coronavirus in late 2019. Fortunately, the Andean variant of hantavirus is not novel and previous outbreaks have been contained, as happened in Epuyen. Yet a combination of simplistic media coverage and public health complacency show little has been learnt since covid.

Nothing to see here attitudes combine with breathless coverage that makes instant comparisons to covid. A similar dynamic played out with monkeypox whereby the next pandemic was emerging from a localised context. Public health guidance is contradictory in its precautionary recommendations, both recognising the potential of respiratory spread of ADV hantavirus while downplaying its significance[1]. The use of air filtration and respiratory measures in the Epuyen outbreak is largely ignored as the emphasis is placed on hantavirus’s deposition origins.

International transportation’s epidemiological modalities are already well known. Despite this, action around air filtration and proximity in potential virological environments has remained limited, particularly in commercial contexts of airplanes and cruise ships. Inadequate filters or poor ventilation are common occurrences as the expense of better air quality is considered too high. Pandemic potential is at the mercy of commercial travel’s balance sheet.

Failing at the basics is nothing new. Continual underinvestment in general healthcare measures and the inflexibility of flu pandemic measures created a situation of flailing around when coronavirus overwhelmed (already) overextended healthcare capacity. Public health failed, and then all hopes became pinned on biosecurity measures and vaccines that put health infrastructure into the hands of private foundations and pharmaceutical corporations.

The groundwork for this had been laid before. Foot and mouth disease presented a vector for centralisation of control over veterinary inoculation and agricultural regulation, leading to unnecessary culling of herds based on statistical miscalculations. Swine flu gave incredible control over disease prevention to pharmaceutical companies, to the tune of billions in profits based on modelled overestimations and changing epidemiological definitions (“for the first time, the WHO criteria for a pandemic was changed in April 2009 as the first Mexico cases were reported, to make not the actual risk of a disease but the number of cases of the disease [the] basis to declare ‘Pandemic’”). This “immunity-as-a-service”[2] model is an extension of a biosecurity architecture that places capital vehicles and surveillance models at the centre of public health strategies, to the detriment of strategies that focus on wider variables (nutrition, fitness, air filtration, ergonomic design, psychological balance, etc.).

Ebola and Zika virus continued this growing trajectory of securitisation and private control. “Ebola was the first disease to formally justify the suspension of normal political and sovereign constraints on a global scale. It established the precedent that health emergencies warrant permanent security architecture, that biological surveillance constitutes prevention, and that crisis governance can be conducted through informal networks of private actors, philanthropic intermediaries, and unelected officials operating parallel to democratic institutions”[3]. Health initiatives that centre vaccines and private funding mechanisms are de rigueur for the construction of monitoring infrastructure, no matter the disease or risk profile.

A vast health network structured around entities like the Gates Foundation, GAVI, JPMorgan, Moderna, Eli Lilly, Pfizer and the Wellcome Trust, encapsulated in Project Molecule (“developed within the JPMorgan–Gates–Epstein ecosystem”[4]), creates a set of incentives emphasising opacity, public surveillance and limited accountability. Project Molecule set out conditions for donor anonymity, governance-by-wealth, infrastructure outside of sovereign control and the limitation of liability.

Biosecurity infrastructure with no oversight, everything from audits to governance being held in-house. “When patents, simulations, capital vehicles, rehearsal events, reinsurance triggers, and internal scope documents all exist before a crisis, what you are looking at is not a conspiracy theory. It is structural readiness for profit—the kind of readiness that rewards speed, centralizes control, and marginalizes alternative approaches”[5]. Such was already in place when coronavirus hit. This architecture of pandemic simulations and communications strategies was ready for the declaration of a global event, even reliant upon it.

Moderna’s business model of vast capital expenditure (and associated overvaluation) and reliance on mRNA vaccine breakthroughs[6] became a plug-and-play system for this biosecurity architecture, requiring cascading crises that ran on the logistical/commercial flows of global trade and movement to justify such a high-risk strategy. Such a crisis helped overcome the roadblocks to profitability, particularly mRNA toxicity noted in early vaccine trials which still shows up in the delivery mechanisms, from cellular inflammation to cross-organ expression with variable immune response[7] (and subsequent immunity drop off requiring a constant schedule of boosters).

Hantavirus shows nothing has changed – the same structures with the same incentives pushing initiatives into the same restrictive avenues. “What they do show—in the participants’ own words—is that pandemics and vaccines were treated as standing financial and strategic categories years before any declared pandemic, complete with capital vehicles, legal frameworks, communications strategies, patent portfolios, simulation programs, reinsurance products, and rehearsal events”[8]. Moderna has already been developing hantavirus vaccines on the mRNA platform[9]. With their capitalisation requirements, short turnarounds and quick delivery are paramount for further profitability. “This viable market requires large swathes of the population to be convinced that they are at far higher risk than they actually are, or coerced into taking it”[10]. All the while, the demonstrable risks of cheap international travel that organises travellers into commercial cattle sheds is ignored. Logistical enterprise creates vectors for fast-spreading respiratory illnesses and vaccine platforms in a wider biosecurity surveillance structure stand poised to provide readymade remedies.

SAGE’s behavioural committee showed what this means psychologically[11] – a population on the perpetual edge of fear ready to ostracise scepticism and accept massively intrusive health interventions irrespective of the epidemiological realities. Hantavirus will not be the cause of a future lockdown. It is rather a product of our existing disaster capitalism that requires a bunker state in perma-lockdown[12] already. Biosecurity protocols are in search of viral outbreaks to continue what the lockdowns accelerated – the upward redistribution of wealth alongside a pliant population whose socio-economic capabilities are closed by epidemiological barriers that mask pre-existing power relations.

---

[1] https://trishgreenhalgh.substack.com/p/fb368a53-f848-4b25-86de-aae5358f52be

[2] https://brownstone.org/articles/your-booster-life-how-big-pharma-adopted-the-subscription-model-of-profitability/

[3] https://sayerji.substack.com/p/epstein-ebola-and-obama-inside-the

[4] https://sayerji.substack.com/p/epstein-ebola-and-obama-inside-the

[5] https://sayerji.substack.com/p/breaking-the-epstein-files-illuminate

[6] https://unlimitedhangout.com/2021/10/investigative-reports/moderna-a-company-in-need-of-a-hail-mary/

[7] https://www.nature.com/articles/s41587-026-03099-z

[8] https://sayerji.substack.com/p/breaking-the-epstein-files-illuminate

[9] https://www.wired.com/story/a-new-hantavirus-vaccine-is-in-the-works/

[10] https://dailysceptic.org/2026/05/11/why-is-the-who-driving-a-hantavirus-panic/

[11] https://assets.publishing.service.gov.uk/media/5ecd084586650c76acac37e0/25-options-for-increasing-adherence-to-social-distancing-measures-22032020.pdf

[12] https://collapsepatchworks.com/2021/10/09/perma-lockdown-and-the-pharmacy/